Lv41
706 积分 2022-06-28 加入
Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial
34分钟前
求助中
1258MO Low dose versus standard dose pembrolizumab for treatment of stage IV stage non-small cell lung carcinoma: Results of the pre-planned interim analysis of the NVALT-30 clinical trial
1个月前
已关闭
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
1个月前
已完结
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
3个月前
已完结
Phase i study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer
3个月前
已关闭
Advances in the management of localized bladder cancers
3个月前
已完结
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy
3个月前
已完结
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
3个月前
已完结
Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin
3个月前
已完结
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
3个月前
已完结
皖公网安备34019202002308
